Case Study: Ajinomoto achieves faster, higher-quality cell culture media development with Genedata Bioprocess

Ajinomoto Speeds Up Cell Culture Media Development Using Genedata Bioprocess

Ajinomoto, a global biotechnology company known for cell culture media such as CELLiST™ and StemFit®, faced the challenge of developing highly complex, component-rich media across distributed R&D and manufacturing teams in Asia. Their historical data was fragmented across legacy systems and spreadsheets, making structured capture, traceability and cross-site analysis difficult. To address this, Ajinomoto selected Genedata and its Genedata Bioprocess platform to centralize and digitalize media development workflows.

Genedata implemented Genedata Bioprocess as a central enterprise workflow and data-management platform, directly importing instrument data (e.g., Ambr‑15, Vi‑CELL BLU, LC‑MS), providing APIs for programmatic access, and automating time‑series calculations like IVCD and specific productivity (Qp). By integrating hundreds of experiments and enabling evaluation of 60+ amino‑acid compositions per run, Genedata Bioprocess has standardized data capture, accelerated decision‑making, shortened development timelines, and significantly increased Ajinomoto’s productivity and media development quality across sites in Japan and Korea (with expansion planned to China).

Ajinomoto

Hiroyuki Mise

General Manager